Search Results 361-370 of 18195 for creatine evidence

1. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   ... evidence of disease; non-measurable disease must ... Serum creatinine =< the IULN OR measured or calculated creatinine ... Patients must not have documented ...

2. Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Calculated creatinine clearance (using Cockcroft-Gault equation) >= 30 mL/min ... Evidence of current uncontrolled cardiovascular conditions, including ...

3. A Study of T-VEC and Radiation to Treat Localized Soft Tissue Sarcoma - Mayo Clinic

   Calculated creatinine clearance > 70 mL/min/1.73 m^2. ... Patients with evidence of active bleeding or bleeding ... Evidence of clinically significant ...

4. Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial - Mayo Clinic

   - Creatinine clearance (CrCL) ≥ 45 mL/min (estimated using ... - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral

5. Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer - Mayo Clinic

   Creatinine =< 1.5 mg/dL OR calculated creatinine clearance of >= 50 ml/min by ... evidence of an immunocompromised state, are eligible for this trial ...

6. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   Creatinine clearance >= 40 mL/min per 24 hour urine collection or the ... History or current evidence of any condition, therapy, or laboratory ...

7. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Subject must have documented evidence of progressive disease (PD) based on ... Creatinine clearance ≤ 20 mL/min/1.73 m2 (may be calculated using the ...

8. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery - Mayo Clinic

   Note: Patients are eligible whether there is residual invasive carcinoma in the surgical breast specimen or whether there is evidence of pathologic complete ...

9. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   * Radiographic evidence of meningioma progression ... * Calculated creatinine clearance must be \>= 40 ... evidence of an immunocompromised state, are eligible for ...

10. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    ... evidence for active thrombosis (either DVT or PE). Stroke ≤ months prior to ... Creatinine ≤ 1.5 x upper limit of normal ULN;; Total Bilirubin ≤ 1.5 ...